These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8915197)
1. The microcirculation in venous hypertension. Smith PD Cardiovasc Res; 1996 Oct; 32(4):789-95. PubMed ID: 8915197 [TBL] [Abstract][Full Text] [Related]
2. The microcirculation in venous hypertension. Coleridge Smith PD Vasc Med; 1997; 2(3):203-13. PubMed ID: 9546969 [TBL] [Abstract][Full Text] [Related]
3. The causes of skin damage and leg ulceration in chronic venous disease. Smith PC Int J Low Extrem Wounds; 2006 Sep; 5(3):160-8. PubMed ID: 16928672 [TBL] [Abstract][Full Text] [Related]
4. Deleterious effects of white cells in the course of skin damage in CVI. Coleridge Smith PD Int Angiol; 2002 Jun; 21(2 Suppl 1):26-32. PubMed ID: 12515977 [TBL] [Abstract][Full Text] [Related]
5. The role of nitric oxide in the pathogenesis of venous ulcers. Nikolovska S; Pavlova L; Ancevski A; Petrov A; Arsovski A; Dejanova E Acta Dermatovenerol Croat; 2005; 13(4):242-6. PubMed ID: 16356399 [TBL] [Abstract][Full Text] [Related]
6. A potential role of interferon-gamma in the pathogenesis of venous leg ulcers. Simka M Med Hypotheses; 2006; 67(3):639-44. PubMed ID: 16735095 [TBL] [Abstract][Full Text] [Related]
7. Microcirculatory dysfunction in chronic venous insufficiency (CVI). Jünger M; Steins A; Hahn M; Häfner HM Microcirculation; 2000; 7(6 Pt 2):S3-12. PubMed ID: 11151969 [TBL] [Abstract][Full Text] [Related]
8. Leukocyte activity in the microcirculation of the leg in patients with chronic venous disease. Saharay M; Shields DA; Porter JB; Scurr JH; Coleridge Smith PD J Vasc Surg; 1997 Aug; 26(2):265-73. PubMed ID: 9279314 [TBL] [Abstract][Full Text] [Related]
10. [Physiopathology of venous stasis at the microcirculation level]. Miani S; Boneschi M; La Penna A; Giordanengo F Minerva Cardioangiol; 1992 Nov; 40(11):413-6. PubMed ID: 1291920 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms and consequences of cell activation in the microcirculation. Mazzoni MC; Schmid-Schönbein GW Cardiovasc Res; 1996 Oct; 32(4):709-19. PubMed ID: 8915189 [TBL] [Abstract][Full Text] [Related]
12. Improvement of microcirculation and healing of venous hypertension and ulcers with Crystacide: evaluation with a microcirculatory model, including free radicals, laser doppler flux, and PO2/PCO2 measurements. Belcaro G; Cesarone MR; Errichi BM; Di Renzo A; Errichi S; Ricci A; Gizzi G; Dugall M; Cacchio M; Ruffini I; Fano F; Vinciguerra G; Grossi MG Angiology; 2007; 58(3):323-8. PubMed ID: 17626987 [TBL] [Abstract][Full Text] [Related]
13. Direct triggers for ulceration in patients with venous insufficiency. Shai A; Halevy S Int J Dermatol; 2005 Dec; 44(12):1006-9. PubMed ID: 16409265 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency. Andreozzi GM Minerva Cardioangiol; 2007 Dec; 55(6):741-53. PubMed ID: 18091643 [TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms in chronic venous insufficiency. Bergan J Ann Vasc Surg; 2007 May; 21(3):260-6. PubMed ID: 17484957 [TBL] [Abstract][Full Text] [Related]
18. Micronized purified flavonoid fraction and the treatment of chronic venous insufficiency: microcirculatory mechanisms. Smith PD Microcirculation; 2000; 7(6 Pt 2):S35-40. PubMed ID: 11151970 [TBL] [Abstract][Full Text] [Related]
19. [The current concept of the pathogenesis of trophic skin lesions in chronic venous insufficiency from the morphologic viewpoint]. Leu HJ Wien Med Wochenschr; 1994; 144(10-11):199-200. PubMed ID: 7856183 [TBL] [Abstract][Full Text] [Related]